Disc Medicine (IRON) Interest Expenses (2020 - 2026)

Disc Medicine (IRON) has reported Interest Expenses for 7 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Interest Expenses rose 35.48% year-over-year to $2.1 million; the TTM figure through Jun 2026 stood at $2.1 million (up 35.48% YoY), while the FY2025 annual figure was $137.0 million, up 28.33% from the prior year.
• Interest Expenses climbed to $2.1 million in Q2 2026 per IRON's latest filing, from $1.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $114.4 million in Q1 2024 and bottomed at $41000.0 in Q3 2022.
• Historically, Interest Expenses has averaged $21.4 million across 5 years, with a median of $1.4 million in 2025.
• Annual changes were most pronounced in 2023 — Interest Expenses soared 210121.95% — and 2025, when it slumped 98.56%.
• Disc Medicine's Interest Expenses stood at $92000.0 in 2022, then jumped by 93585.87% to $86.2 million in 2023, then plunged by 99.34% to $572000.0 in 2024, then soared by 53.15% to $876000.0 in 2025, then soared by 139.73% to $2.1 million in 2026.
• Business Quant data shows IRON's Interest Expenses at $2.1 million in Q2 2026, $1.3 million in Q1 2026, and $876000.0 in Q4 2025.